Alinidine

DB20618ExperimentalSmall molecule

Alinidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Alinidine is a a2 adrenoreceptor agonist. Alinidine has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1
Curator reviewed
Formula / weight: C₁₂H₁₃Cl₂N₃ · 270.16 g/mol (avg)
Code names: ST-567 · ST 567-BR (AS HBR) · ST 567-BR (AS HYDROBROMIDE)

Resolves to

Compound

UNIIE7IDJ8DS1DCAS33178-86-8ChEMBLCHEMBL278581ChEBI748020PubChem36354

Structure

InChIKeyOXTYVEUAQHPPMV-UHFFFAOYSA-NSMILESClC1=CC=CC(Cl)=C1N(CC=C)C1=NCCN1

Targets

O60741HCN1Q14654KCNJ11

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Alinidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account